Ensign Peak Advisors, Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q1 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 48,541 shares of ARWR stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,541

Previous 50,990 4.8%

Holding current value

$1.22 Million

Previous $1.56 Million 11.03%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$27.21 - $39.48 $66,637 - $96,686	-2,449 Reduced 4.8%	48,541 $1.39 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $3.02 Million - $4.91 Million	-127,470 Reduced 71.43%	50,990 $1.3 Million
Q4 2022 Feb 13, 2023	BUY	$28.0 - $40.56 $516,600 - $748,332	18,450 Added 11.53%	178,460 $7.24 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $660,867 - $1.08 Million	22,304 Added 16.2%	160,010 $5.29 Million
Q2 2022 Aug 12, 2022	BUY	$27.79 - $50.61 $2.9 Million - $5.29 Million	104,446 Added 314.03%	137,706 $4.85 Million

Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $46,553 - $82,214	-1,175 Reduced 3.41%	33,260 $1.53 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $2.85 Million - $4.05 Million	-49,065 Reduced 58.76%	34,435 $2.28 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $1.03 Million - $1.49 Million	-17,596 Reduced 17.41%	83,500 $5.21 Million
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $333,745 - $485,018	-5,370 Reduced 5.04%	101,096 $8.37 Million
Q1 2021 May 12, 2021	SELL	$61.35 - $90.47 $251,903 - $371,469	-4,106 Reduced 3.71%	106,466 $7.06 Million
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $685,257 - $1.34 Million	-15,638 Reduced 12.39%	110,572 $8.48 Million
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $1.22 Million - $1.88 Million	36,600 Added 40.84%	126,210 $5.44 Million
Q2 2020 Aug 12, 2020	SELL	$26.12 - $43.27 $584,226 - $967,820	-22,367 Reduced 19.97%	89,610 $3.87 Million
Q1 2020 May 11, 2020	BUY	$20.56 - $63.12 $75,681 - $232,344	3,681 Added 3.4%	111,977 $3.22 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $3.05 Million - $7.91 Million	108,296 New	108,296 $6.87 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Arrowhead Pharmaceuticals, Inc. Transaction History